Associations between obesity, diabetes mellitus, and cardiovascular disease with progression states of knee osteoarthritis (KOA)
- PMID: 36525243
- DOI: 10.1007/s40520-022-02312-8
Associations between obesity, diabetes mellitus, and cardiovascular disease with progression states of knee osteoarthritis (KOA)
Abstract
Background: Data on common comorbidities targeting at different progression states of knee osteoarthritis (KOA) in continuous time are limited.
Aims: To examine the associations between obesity, diabetes mellitus (DM), and cardiovascular disease (CVD) with the progression of KOA.
Methods: Data were obtained from the Osteoarthritis Initiative for up to 48 months. Progression states of KOA were defined as (1) normal; (2) asymptomatic radiographic KOA (RKOA, Kellgren-Lawrence grade ≥ 2 in at least one knee); (3) only knee symptoms; (4) symptomatic KOA (SxKOA, a combination of RKOA and knee symptoms in the same knee). A multi-state Markov model was used to investigate the associations while accounting for potential confounders.
Results: Participants with obesity had an increased risk of developing RKOA [normal to asymptomatic RKOA, adjusted hazard ratio (aHR) 1.55, 95% confidence interval (95% CI) (1.07, 2.24); only knee symptoms to SxKOA, aHR 2.25, 95% CI (1.60, 3.18)], and an increased risk of developing knee symptoms [normal to only knee symptoms, aHR 1.45, 95% CI (1.15, 1.83); asymptomatic RKOA to SxKOA, aHR 1.33, 95% CI (1.16, 1.52)]. DM was also significantly associated with development of RKOA or knee symptoms [normal to asymptomatic RKOA, aHR 1.92, 95% CI (1.12, 3.30); normal to only knee symptoms, aHR 1.78, 95% CI (1.12, 2.84)]. Knee symptoms were less likely to be relieved among participants with CVD, compared with those without [only knee symptoms to normal, aHR 0.60, 95% CI (0.38, 0.94)].
Conclusions: Obesity, DM and CVD are associated with an increased risk for SxKOA progression. Common comorbidities should be considered to prevent KOA development.
Keywords: Comorbidities; Knee osteoarthritis; Markov model; Progression.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
References
-
- Hunter DJ, Bierma-Zeinstra S (2019) Osteoarthritis. Lancet 393:1745–1759. https://doi.org/10.1016/s0140-6736(19)30417-9 - DOI
-
- GBD (2019) Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396:1204–1222. https://doi.org/10.1016/s0140-6736(20)30925-9 - DOI
-
- Long H, Liu Q, Yin H et al (2022) Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019. Arthritis Rheumatol 74:1172–1183. https://doi.org/10.1002/art.42089 - DOI
-
- Silverwood V, Blagojevic-Bucknall M, Jinks C et al (2015) Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthr Cartil 23:507–515. https://doi.org/10.1016/j.joca.2014.11.019 - DOI
-
- Zhang Y, Jordan JM (2008) Epidemiology of osteoarthritis. Rheum Dis Clin North Am 34:515–529. https://doi.org/10.1016/j.rdc.2008.05.007 - DOI
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
